3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Surgery
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Neoadjuvant Chemoimmunotherapy
1
Menstruation Disturbances
1
Leiomyoma
1
Invasive Breast Carcinoma
1
Endometriosis
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Adenomyosis
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
fludarabine
1
Sirolimus
1
Robotic Surgical Procedures
1
Patient Reported Outcome Measures
1
Methotrexate
1
Mesna
1
Hysterectomy
1
Etoposide
1
Cyclosporine
1
CPI-0610
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Robotic Surgical Procedures
×
90 days
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled